Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, School of Medicine, University of Patras, 26504, Patras, Greece.
Laboratory of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, University of Patras, 26504, Patras, Greece.
Hormones (Athens). 2020 Sep;19(3):433-438. doi: 10.1007/s42000-020-00189-8. Epub 2020 Mar 27.
Oxidative stress is closely related to type 1 diabetes mellitus (T1DM), playing a key role in the pathogenesis of the disease and progression of complications. It is characterized by loss of equilibrium between oxidative factors and antioxidant protective mechanisms. Several markers have been used to assess both components of oxidative status; two of which are malondialdehyde (MDA) and ferric reducing antioxidant power (FRAP).
We investigated glycated hemoglobin (HbA1c), lipid profile, MDA, and FRAP in 35 patients with T1DM, aged 2-23 years, at the end of two 4-month observational periods: period A: standard insulin dosing per meal, and period B: proper prandial insulin dosing based on the amount of carbohydrates contained in each meal.
At the end of period B, (i) glucose control (HbA1c) was improved; (ii) oxidative stress, estimated by MDA, showed a tendency to decrease; and (iii) antioxidant capacity, estimated by FRAP, was significantly increased compared with that of period A. No significant differences were observed in the lipid profile of the patients between the two periods.
Proper insulin dosing based on carbohydrate counting (CC) may have an impact on the antioxidant defensive mechanisms of patients with T1DM through the attainment of a better glycemic profile. There are also indications that it may reduce MDA, an important biomarker of oxidative stress and a significant mediator of complications in T1DM. Therefore, prompt dietetic intervention using CC as early as possible after the diagnosis of T1DM is important for achieving optimal glycemic control and improved oxidative status.
氧化应激与 1 型糖尿病(T1DM)密切相关,在疾病发病机制和并发症进展中起关键作用。其特征是氧化因素和抗氧化保护机制之间失去平衡。已经使用了几种标志物来评估氧化状态的两个组成部分;其中两种是丙二醛(MDA)和铁还原抗氧化能力(FRAP)。
我们在两个 4 个月的观察期结束时,调查了 35 名 2-23 岁的 T1DM 患者的糖化血红蛋白(HbA1c)、血脂谱、MDA 和 FRAP:时期 A:每餐标准胰岛素剂量;时期 B:根据每餐所含碳水化合物的量进行适当的餐前胰岛素剂量。
在时期 B 结束时,(i)血糖控制(HbA1c)得到改善;(ii)氧化应激,用 MDA 估计,显示出降低的趋势;(iii)用 FRAP 估计的抗氧化能力与时期 A 相比显著增加。两个时期患者的血脂谱没有显著差异。
基于碳水化合物计数(CC)的适当胰岛素剂量可能通过实现更好的血糖谱对 T1DM 患者的抗氧化防御机制产生影响。也有迹象表明,它可能降低 MDA,MDA 是氧化应激的一个重要生物标志物,也是 T1DM 并发症的一个重要介质。因此,在诊断 T1DM 后尽早使用 CC 进行饮食干预对于实现最佳血糖控制和改善氧化状态非常重要。